Motilal Oswal Financial Services has issued a buy call for Apollo Hospitals Enterprise, setting a target price of Rs 8,020. They project a 20% EBITDA CAGR and 18% PAT CAGR for the company from FY24 to FY27. This positive outlook is driven by anticipated growth in Healthco’s profitability, increased patient capacity, and strong performance in the diagnostics sector.
Subscribe To Our Free Newsletter |